THE US FDA has approved
Repro-Med Systems’ HIgh Flo
RMS Subcutaneous Needle Sets
for the delivery of medication
to subcutaneous tissue.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 02 Jun 11 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jun 11
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.